Urinary kidney injury molecules in children with iron-deficiency anemia

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 4023-4029

  Güneş, Ali ^a   Ece, Aydın ^a   Aktar, Fesih ^a   Tan, İlhan ^a   Söker, Murat ^a   Karabel, Duran ^a   Balık, Hasan ^a   Uluca, Ünal ^a   Şen, Velat ^a   Yolbaş, İlyas ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Anemia; Early diagnosis; Iron deficiency; Kidney diseases

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CALCIUM; CREATININE; FATTY ACID BINDING PROTEIN; FERRITIN; GLUCOSE; HEMOGLOBIN; IRON; KIDNEY INJURY MOLECULE 1; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; POTASSIUM; SODIUM; UREA; ACETYLGLUCOSAMINIDASE; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; ELECTROLYTE; FABP1 PROTEIN, HUMAN; HAVCR1 PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN; LIPOCALIN; MEMBRANE PROTEIN; ONCOPROTEIN; VIRUS RECEPTOR;

ARTICLE; CHEMICAL ANALYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE COUNT; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IRON BINDING CAPACITY; IRON DEFICIENCY ANEMIA; KIDNEY INJURY; MALE; PRESCHOOL CHILD; PROSPECTIVE STUDY; BLOOD; CASE CONTROL STUDY; COMPLICATION; KIDNEY DISEASE; KIDNEY FUNCTION TEST; METABOLISM; URINE;

ACETYLGLUCOSAMINIDASE; ACUTE-PHASE PROTEINS; ANEMIA, IRON-DEFICIENCY; BIOMARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CREATININE; ELECTROLYTES; FATTY ACID-BINDING PROTEINS; FEMALE; HEMOGLOBINS; HEPATITIS A VIRUS CELLULAR RECEPTOR 1; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; LIPOCALIN-2; LIPOCALINS; MALE; MEMBRANE GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS;

EID: 84952329530     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.896794     Document Type: Article

References (31)

1. Charles CV, Summerlee AJ, Dewey CE: Anemia in Cambodia: Prevalence, etiology and research needs. Asia Pac J Clin Nutr, 2012; 21: 171-81
2. Bazmamoun H, Razavi Z, Esfahani H, Arefian: Evaluation of Iron deficiency anemia and BMI in children suffering from Helicobacter pylori infection. Iran J Ped Hematol Oncol, 2014; 4: 167-71
3. Pasricha SR, Drakesmith H, Black J et al: Control of iron deficiency anemia in low-and middle-income countries. Blood, 2013; 121: 2607-17
4. Nangaku M: Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol, 2006; 17: 17-25
5. Argyri I, Xanthos T, Varsami M et al: The role of novel biomarkers in early diagnosis and prognosis of acute kidney injury in newborns. Am J Perinatol, 2013; 30: 347-52
6. Du Y, Hou L, Guo J et al: Renal neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 expression in children with acute kidney injury and Henoch-Schonlein purpura nephritis. Exp Ther Med, 2014; 7: 1130-34
7. Darby PJ, Kim N, Hare GM: Anemia increases the risk of renal cortical and medullary hypoxia during cardiopulmonary bypass. Perfusion, 2013; 28: 504-11
8. Ragoonanan TE, Beattie WS, Mazer CD et al: Metoprolol reduces cerebral tissue oxygen tension after acute hemodilution in rats. Anesthesiology, 2009; 111: 988-1000
9. Martensson J, Martling CR, Bell M: Novel biomarkers of acute kidney injury and failure: clinical applicability. Br J Anaesth, 2012; 109: 843-50
10. McCullough PA, Bouchard J, Waikar SS et al: Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol, 2013; 182: 5-12
11. Vaidya VS, Ferguson MA, Bonventre JV: Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol, 2008; 48: 463-93
12. Obermüller N, Geiger H, Weipert C, Urbschat A: Current developments in early diagnosis of acute kidney injury. Int Urol Nephrol, 2014; 46: 1-7
13. Holzscheiter L, Beck C, Rutz S et al: NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction. Clin Chem Lab Med, 2014; 52: 537-46
14. Scott SP, Chen-Edinboro LP, Caulfield LE, Murray-Kolb LE: The impact of anemia on child mortality: an updated review. Nutrients, 2014; 6: 5915-32
15. Subramaniam G, Girish M: Iron deficiency anemia in children. Indian J Pediatr, 2015; 82: 558-64
16. Fufaa GD, Weil EJ, Nelson RG et al: Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus. Diabetologia, 2015; 58: 188-98
17. Schreiber MJ Jr: Minimizing perioperative complications in patients with renal insufficiency. Cleve Clin J Med, 2006; 73: 116-20
18. Mohanram A, Zhang Z, Shahinfar S et al: Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney Int, 2004; 66: 1131-38
19. Flower DR, North AC, Sansom CE: The lipocalin protein family: structural and sequence overview. Biochim Biophys Acta, 2000; 1482: 9-24
20. Yazdani M, Merrikhi A, Beni ZN et al: Association between neutrophil geletinase-associated lipocalin and iron deficiency anemia in children on chronic dialysis. J Res Med Sci, 2014; 19: 624-28
21. Sen V, Ece A, Uluca I et al: Urinary early kidney injury molecules in children with beta-thalassemia major. Leukemia Research, 2014; 38: S56-57
22. Bernard AM, Vyskocil AA, Mahieu P, Lauwerys RR: Assessment of urinary retinol-binding protein as an index of proximal tubular injury. Clin Chem, 1987; 33: 775-79
23. Price RG: The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Clin Nephrol, 1992; 38: S14-19
24. Han WK, Bailly V, Abichandani R et al: Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int, 2002; 62: 237-44
25. Luo Q, Zhou F, Dong H et al: Implication of combined urinary biomarkers in early diagnosis of acute kidney injury following percutaneous coronary intervention. Clin Nephrol, 2013; 79: 85-92
26. Manabe K, Kamihata H, Motohiro M et al: Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury. Eur J Clin Invest, 2012; 42: 557-63
27. Przybylowski P, Koc-Zorawska E, Malyszko JS et al: Liver fatty-acid-binding protein in heart and kidney allograft recipients in relation to kidney function. Transplant Proc, 2011; 43: 3064-67
28. Kamijo A, Sugaya T, Hikawa A et al: Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Mol Cell Biochem, 2006; 284: 175-82
29. Yokoyama T, Kamijo-Ikemori A, Sugaya T et al: Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage. Am J Pathol, 2009; 174: 2096-106
30. Ferguson MA, Vaidya VS, Waikar SS et al: Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int, 2010; 77: 708-14
31. Matsui K, Kamijo-Ikemori A, Sugaya T et al: Usefulness of urinary biomarkers in early detection of acute kidney injury after cardiac surgery in adults. Circ J, 2012; 76: 213-20